Natco Pharma Board to meet on Sep 25, 2026 for ₹1,300 Cr Rights Issue

Natco Pharma Ltd has announced that its Board of Directors will convene on September 25, 2026. The primary agenda for this meeting is to consider, discuss, and finalize various aspects related to the previously approved rights issue, which aims to raise an amount not exceeding ₹1,300 crores. Key terms to be determined include the rights issue price, payment mechanism, rights entitlement ratio, record date, and the overall timing of the rights issue. In compliance with SEBI regulations, the trading window for designated persons and their relatives will be closed from September 23, 2026, until 48 hours after the board meeting outcome is intimated to the stock exchanges.